{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,20]],"date-time":"2026-01-20T14:41:20Z","timestamp":1768920080397,"version":"3.49.0"},"reference-count":29,"publisher":"Wiley","license":[{"start":{"date-parts":[[2023,10,11]],"date-time":"2023-10-11T00:00:00Z","timestamp":1696982400000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Case Reports in Infectious Diseases"],"published-print":{"date-parts":[[2023,10,11]]},"abstract":"<jats:p>Background. Adverse events after vaccination against COVID-19 include rare events, such as Guillain\u2013Barr\u00e9 syndrome. Study Aims. Documentation of clinical and temporary characteristics of the Guillain\u2013Barr\u00e9 syndrome after using anti-COVID-19 ChAdOx1 nCoV-19 vaccine. Case Presentation. An adult, 29-year-old male, without relevant medical history, who developed neuromuscular symptoms nine days after administration of the first dose of anti-COVID-19 ChAdOx1 nCoV-19 vaccine. Results. Symptoms appeared nine days after vaccination, with lower limbs paresthesia. Three days later, paresthesia of upper limbs occurred. The following day, distal weakness of limbs, with standing and gripping difficulties, occurred. The clinical evaluation demonstrated dysarthria, incomplete palpebral closure, bilateral facial, and tongue paresis. The electromyography was compatible with a motor demyelinating polyneuropathy, confirming the diagnosis of the Guillain\u2013Barr\u00e9 syndrome. Management with five sessions of plasma exchange was prescribed, with favorable clinical results. Conclusions. Clinical and laboratory tests confirmed the Guillain\u2013Barr\u00e9 syndrome and the time elapsed from the date of the vaccine administration to the appearance of initial symptoms, added to the absence of other causes, and allowed to establish that the disease was caused by the vaccination.<\/jats:p>","DOI":"10.1155\/2023\/3290956","type":"journal-article","created":{"date-parts":[[2023,10,11]],"date-time":"2023-10-11T20:50:33Z","timestamp":1697057433000},"page":"1-4","source":"Crossref","is-referenced-by-count":2,"title":["Guillain\u2013Barr\u00e9 Syndrome Post COVID-19 Vaccination with ChAdOx1 nCoV-19 Vaccine: A Colombian Case Report"],"prefix":"10.1155","volume":"2023","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3625-4892","authenticated-orcid":true,"given":"Isabel Cristina","family":"Hurtado","sequence":"first","affiliation":[{"name":"Grupo de Vigilancia en Salud P\u00fablica, Secretar\u00eda Departamental de Salud del Valle del Cauca, Cali, Colombia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0692-5077","authenticated-orcid":true,"given":"Raul","family":"Vallejo-Serna","sequence":"additional","affiliation":[{"name":"Hospital Universitario del Valle Evaristo Garc\u00eda, Cali, Colombia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6580-9829","authenticated-orcid":true,"given":"Juan Sebastian","family":"Hurtado-Zapata","sequence":"additional","affiliation":[{"name":"Grupo de Vigilancia en Salud P\u00fablica, Secretar\u00eda Departamental de Salud del Valle del Cauca, Cali, Colombia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9446-4831","authenticated-orcid":true,"given":"Sandra Patricia","family":"Misnaza","sequence":"additional","affiliation":[{"name":"Grupo de Vigilancia en Salud P\u00fablica, Secretar\u00eda Departamental de Salud del Valle del Cauca, Cali, Colombia"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","reference":[{"key":"1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(20)32466-1"},{"key":"2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.n1786"},{"key":"3","article-title":"Meeting highlights from the pharmacovigilance risk assessment committee (PRAC) 5-8 july 2021","author":"European Medicine Agency","year":"2021"},{"key":"4","doi-asserted-by":"publisher","DOI":"10.1016\/j.neurop.2021.09.002"},{"key":"5","doi-asserted-by":"publisher","DOI":"10.1111\/cen3.12678"},{"key":"6","doi-asserted-by":"publisher","DOI":"10.1016\/j.jneuroim.2021.577691"},{"key":"7","doi-asserted-by":"publisher","DOI":"10.1002\/ana.26143"},{"key":"8","doi-asserted-by":"publisher","DOI":"10.32598\/bcn.2021.3565.1"},{"key":"9","doi-asserted-by":"publisher","DOI":"10.1016\/j.clineuro.2021.106887"},{"key":"10","doi-asserted-by":"publisher","DOI":"10.1136\/bcr-2021-242956"},{"key":"11","doi-asserted-by":"publisher","DOI":"10.1002\/ana.26144"},{"key":"12","doi-asserted-by":"publisher","DOI":"10.12691\/ajmcr-9-8-10"},{"key":"13","doi-asserted-by":"publisher","DOI":"10.1136\/bcr-2021-244527"},{"key":"14","doi-asserted-by":"publisher","DOI":"10.1136\/bcr-2021-243629"},{"key":"15","doi-asserted-by":"publisher","DOI":"10.1016\/j.jneuroim.2021.577719"},{"key":"16","article-title":"Informe anual de vigilancia en salud p\u00fablica de eventos de inter\u00e9s en salud p\u00fablica, Valle del Cauca, a\u00f1o 2021","author":"Secretar\u00eda Departamental de Salud del Valle del Cauca","year":"2021"},{"key":"17","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(20)30120-1"},{"key":"18","article-title":"Casos COVID Colombia, 2020-2021","author":"Instituto Nacional de Salud de Colombia","year":"2021"},{"key":"19","article-title":"Farmacovigilancia de vacunas","author":"Definiciones Clave Sobre Eventos Adversos Posteriores a La Vacunaci\u00f3n (Eapv)","year":"2021"},{"key":"20","doi-asserted-by":"publisher","DOI":"10.4103\/ijph.ijph"},{"key":"21","doi-asserted-by":"publisher","DOI":"10.3201\/eid2712.211634"},{"key":"22","doi-asserted-by":"publisher","DOI":"10.1093\/glycob\/cwab032"},{"key":"23","doi-asserted-by":"publisher","DOI":"10.1016\/J.CLINEURO.2021.106887"},{"key":"24","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(21)00517-1"},{"key":"25","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(16)00339-1"},{"key":"26","doi-asserted-by":"publisher","DOI":"10.1136\/bcr-2021-245816"},{"key":"27","article-title":"Guillain barre syndrome. StatPearls","author":"T. P. Nguyen","year":"2022"},{"key":"28","first-page":"10","article-title":"Descripci\u00f3n estad\u00edstica del COVID- 19 seg\u00fan el grupo etario en Colombia","volume":"29","author":"J. E. Diaz-Pinz\u00f3n","year":"2020","journal-title":"Obesidad: Un Problema En La Atenci\u00f3n De Covid-19"},{"key":"29","doi-asserted-by":"publisher","DOI":"10.22379\/24224022365"}],"container-title":["Case Reports in Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/downloads.hindawi.com\/journals\/criid\/2023\/3290956.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/downloads.hindawi.com\/journals\/criid\/2023\/3290956.xml","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/downloads.hindawi.com\/journals\/criid\/2023\/3290956.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,11]],"date-time":"2023-10-11T20:50:37Z","timestamp":1697057437000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.hindawi.com\/journals\/criid\/2023\/3290956\/"}},"subtitle":[],"editor":[{"given":"Amitis","family":"Ramezani","sequence":"additional","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2023,10,11]]},"references-count":29,"alternative-id":["3290956","3290956"],"URL":"https:\/\/doi.org\/10.1155\/2023\/3290956","relation":{},"ISSN":["2090-6633","2090-6625"],"issn-type":[{"value":"2090-6633","type":"electronic"},{"value":"2090-6625","type":"print"}],"subject":[],"published":{"date-parts":[[2023,10,11]]}}}